Cover American Journal of Veterinary Research
American Journal of Veterinary Research
ISSN:
0002-9645
Publication Date:
01 Mar 2019

  • 1. Voss JL, Sullivan JJ, Pickett BW, et al. The effect of HCG on duration of oestrus, ovulation time and fertility in mares. J Reprod Fertil Suppl 1975;23:297–301.

    • Search Google Scholar
    • Export Citation

  • 2. Hemberg E, Lundeheim N, Einarsson S. Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen. Reprod Domest Anim 2006;41:535–537.

    • Search Google Scholar
    • Export Citation

  • 3. Davies Morel MC, Newcombe JR. The efficacy of different hCG dose rates and the effect of hCG treatment on ovarian activity: ovulation, multiple ovulation, pregnancy, multiple pregnancy, synchrony of multiple ovulation; in the mare. Anim Reprod Sci 2008;109:189–199.

    • Search Google Scholar
    • Export Citation

  • 4. Loomis PR. The equine frozen semen industry. Anim Reprod Sci 2001;68:191–200.

  • 5. Samper JC. Management and fertility of mares bred with frozen semen. Anim Reprod Sci 2001;68:219–228.

  • 6. Canisso IF, Gallacher K, Gilbert MA, et al. Preovulatory progestagen treatment in mares fails to delay ovulation. Vet J 2013;197:324–328.

    • Search Google Scholar
    • Export Citation

  • 7. Armstrong DT. Prostaglandins and follicular functions. J Reprod Fertil 1981;62:283–291.

  • 8. Murdoch WJ, Hansen TR, McPherson LA. A review—role of eicosanoids in vertebrate ovulation. Prostaglandins 1993;46:85–115.

  • 9. Cuervo-Arango J. The effect of treatment with flunixin meglumine at different times relative to hCG administration on ovulation failure and luteal function in mares. Anim Reprod Sci 2011;127:84–90.

    • Search Google Scholar
    • Export Citation

  • 10. Cuervo-Arango J. The effect of systemic administration of cloprostenol on ovulation in mares treated with a prostaglandin synthetase inhibitor. Reprod Domest Anim 2012;47:32–38.

    • Search Google Scholar
    • Export Citation

  • 11. Ginther OJ, Cuervo-Arango J, Beg MA. Disruption of periovulatory FSH and LH surges during induced anovulation by an inhibitor of prostaglandin synthesis in mares. Anim Reprod Sci 2011;126:91–95.

    • Search Google Scholar
    • Export Citation

  • 12. Cuervo-Arango J, Domingo-Ortiz R. Systemic treatment with high dose of flunixin-meglumine is able to block ovulation in mares by inducing hemorrhage and luteinisation of follicles. Theriogenology 2011;75:707–714.

    • Search Google Scholar
    • Export Citation

  • 13. Cuervo-Arango J, Beg MA, Ginther OJ. Follicle and systemic hormone interrelationships during induction of luteinized unruptured follicles with a prostaglandin inhibitor in mares. Theriogenology 2011;76:361–373.

    • Search Google Scholar
    • Export Citation

  • 14. Bashir ST, Gastal MO, Tazawa SP, et al. The mare as a model for luteinized unruptured follicle syndrome: intrafollicular endocrine milieu. Reproduction 2016;151:271–283.

    • Search Google Scholar
    • Export Citation

  • 15. Ginther OJ, Gastal MO, Gastal EL, et al. Induction of haemorrhagic anovulatory follicles in mares. Reprod Fertil Dev 2008;20:947–954.

  • 16. Lima AG, Costa LC, Alvarenga MA, et al. Does clinical treatment with phenylbutazone and meloxicam in the pre-ovulatory period influence the ovulation rate in mares? Reprod Domest Anim 2015;50:771–775.

    • Search Google Scholar
    • Export Citation

  • 17. Lee CD, Maxwell LK. Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and Quarter Horses. J Vet Pharmacol Ther 2014;37:35–42.

    • Search Google Scholar
    • Export Citation

  • 18. Bertone JJ, Horspool LJI. Chapter 8. In: Equine clinical pharmacology. Philadelphia: Saunders, 2014;138.

  • 19. Soma LR, Behrend E, Rudy J, et al. Disposition and excretion of flunixin meglumine in horses. Am J Vet Res 1988;49:1894–1898.

  • 20. Richard H, Appleton P, Kesler DJ, et al. Progesterone supplementation day 3 to 5 postovulation in AI-bred mares. Reprod Fertil Dev 2013;25:153.

    • Search Google Scholar
    • Export Citation

Advertisement

Editorial Type:
Theriogenology

Effects of flunixin meglumine on postponement of ovulation in mares

Callum G. Donnelly BVSc1,2, Jenny L. Sones DVM, PhD3,4, Jenna C. Dockweiler DVM, MSc5,6, Lauren A. Norberg BS7,8, Lindsey E. Norberg BS9,10, Soon H. Cheong DVM, PhD11, and Robert O. Gilbert BVSc, MMedVet12,13
View More View Less
  • 1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
  • | 2 Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
  • | 3 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
  • | 4 Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.
  • | 5 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
  • | 6 Wheat Ridge Animal Hospital, 10140 W 44th Ave, Wheat Ridge, CO 80033.
  • | 7 College of Veterinary Medicine, Auburn University, Auburn, AL 36849.
  • | 8 Midstate Veterinary Services, 37E Main St, Dryden, NY 1503.
  • | 9 College of Veterinary Medicine, Auburn University, Auburn, AL 36849.
  • | 10 College Mall Veterinary Hospital, 3400 South Sare Rd, Bloomington, IN 47401.
  • | 11 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
  • | 12 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
  • | 13 Department of Clinical Sciences, School of Veterinary Medicine, Ross University, Basseterre, St Kitts and Nevis.
DOI:
https://doi.org/10.2460/ajvr.80.3.306
Volume/Issue:
Volume 80: Issue 3
Online Publication Date:
01 Mar 2019
Restricted access
Reprints and Permissions Purchase Article

Abstract

OBJECTIVE To evaluate use of flunixin meglumine as a treatment to postpone ovulation in mares, mare fertility after flunixin meglumine treatment during estrous cycles, and effects of flunixin meglumine on function of the corpus luteum after ovulation.

ANIMALS 13 healthy mares.

PROCEDURES A single-blinded, placebo-controlled, crossover study was conducted. Flunixin meglumine (1.1 mg/kg, IV, q 24 h) or lactated Ringer solution (placebo treatment) was administered for 2 days to mares with a dominant follicle (≥ 35 mm in diameter) and behavioral signs of estrus. Mares then were bred by artificial insemination. Number of days to ovulation from initial detection of a follicle ≥ 30 mm in diameter, uterine edema score, and pregnancy were determined by ultrasonography; the examiner was unaware of the treatment of each mare. Serum progesterone concentrations were evaluated 5 and 12 days after ovulation by use of radioimmunoassay.

RESULTS Data were available for 45 estrus cycles of the 13 mares. Number of days to ovulation from initial detection of a follicle ≥ 30 mm was not significantly affected by administration of flunixin meglumine versus the placebo. Per-cycle pregnancy rate was not significantly different between flunixin meglumine (20/24 [83%] breedings) and the placebo (13/19 [68%] breedings). Flunixin meglumine did not significantly affect behavioral signs of estrus, uterine edema, or serum progesterone concentrations.

CONCLUSIONS AND CLINICAL RELEVANCE Findings did not support the use of flunixin meglumine to postpone ovulation in mares.

Contributor Notes

Address correspondence to Dr. Donnelly (cgdonnelly@ucdavis.edu)